CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Public Meeting on Patient-Focused Drug Development for Long COVID - 04/25/2023

Neutral
AI Analysis

Summary

The FDA is hosting a virtual public meeting on April 25, 2023, to gather patient input on Long COVID and its impact on daily life as part of its Patient-Focused Drug Development initiative.

Importance:2/10
Sentiment:
0.00
Long COVIDPatient-Focused Drug DevelopmentFDA MeetingPublic Meeting

Read the original article

Published by FDA Drugs (New Approvals & NDA) on September 24, 2026 5:46 PM

Read Original